Exhibit
32
CERTIFICATION PURSUANT TO 18
U.S.C.
SECTION 1350 AS ADOPTED
PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF
2002
This
certification set forth below is hereby made solely for the purposes of
satisfying the requirements of Section 906 of the Sarbanes-Oxley Act of
2002 and may not be relied upon or used for any other purposes.
A signed
original of this written statement required by Section 906 has been provided to
Access Pharmaceuticals, Inc. and will be retained by Access Pharmaceuticals,
Inc. and furnished to the SEC or its staff upon its request.
Pursuant
to Section 906 of the Public Company Accounting Reform and Investor Act of 2002
(18 U.S.C. 1350, as adopted, the “Sarbanes-Oxley Act”), Jeffrey B. Davis, Chief
Executive Officer of Access Pharmaceuticals, Inc. (the "Company"), and Stephen
B. Thompson, Vice President and Chief Financial Officer of the Company, each
hereby certifies that to his knowledge the Annual Report on Form 10-KSB for the
period ended December 31, 2007 of the Company filed with the Securities and
Exchange Commission on the date hereof (the "Report") fully complies with the
requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934
and the information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company for
the period specified.
Signed at
the City of Dallas, in the State of Texas, this 31st day of March,
2008.
/s/ Jeffrey B.
Davis /s/ Stephen B.
Thompson
Jeffrey
B.
Davis Stephen
B. Thompson
Chief
Executive
Officer Chief Financial
Officer